EVH - Evolent Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
732,766
627,063
434,950
254,188
96,878
Cost of Revenue
412,671
327,825
269,352
155,177
57,398
Gross Profit
320,095
299,238
165,598
99,011
39,480
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
264,259
235,418
205,670
160,692
75,286
Total Operating Expenses
428,356
350,822
238,038
177,916
82,452
Operating Income or Loss
-108,261
-51,584
-72,440
-78,905
-42,972
Interest Expense
10,958
5,484
3,636
-
-
Total Other Income/Expenses Net
6,231
-523
-1,984
-159,351
385,968
Income Before Tax
-109,596
-54,151
-76,404
-237,533
343,289
Income Tax Expense
1,048
40
-6,637
-10,755
23,475
Income from Continuing Operations
-110,644
-54,191
-69,767
-226,778
319,814
Net Income
-107,470
-52,658
-60,665
-159,742
332,494
Net Income available to common shareholders
-107,470
-52,658
-60,665
-159,742
330,310
Reported EPS
Basic
-
-0.68
-0.94
-3.55
13.14
Diluted
-
-0.68
-0.94
-3.55
6.93
Weighted average shares outstanding
Basic
-
77,338
64,351
45,031
25,129
Diluted
-
77,338
64,351
45,031
46,136
EBITDA
-
-4,152
-40,400
-61,681
-35,806